Arrive AI (NASDAQ:ARAI – Get Free Report) announced its earnings results on Thursday. The company reported ($0.09) earnings per share for the quarter, Zacks reports. Arrive AI had a negative return on equity of 0.95% and a negative net margin of 13,348.06%.
Here are the key takeaways from Arrive AI’s conference call:
- Commercial pipeline is expanding across healthcare, manufacturing, specialty pharmacy, and autonomous delivery. The company cited later-stage discussions, Hancock Regional Hospital’s additional deployment, and partnerships with Nexus AMR and DXC, though only signed agreements will be treated as firm.
- Arrive AI expects more than a dozen AP3 Plus units to be in stock and ready to ship by mid-September, while AP4 is targeted for the first quarter of 2027. Management said the AP4 supply chain is designed to support hundreds of units during 2027, with later generations intended to scale further.
- Financial results remain very small relative to the company’s spending needs. Second-quarter revenue was $14,700, while net loss was $14.1 million, or $4.3 million excluding $9.7 million of non-cash note-conversion expenses; cash and liquid investments totaled $5.1 million against an approximately $1.1 million monthly burn rate.
- Management emphasized that additional financing will be needed or may be pursued, citing a $100 million S-3 registration, a potential $15 million ATM offering, and $19 million of remaining equity-line capacity. Executives said the company is not at immediate risk of running out of funds, but these financing options could result in dilution and reflect ongoing liquidity pressure.
- The company highlighted a growing intellectual-property portfolio, including 10 issued U.S. patents, 13 international patents—primarily in Asia—and a recently approved European patent. Arrive AI plans to explore licensing opportunities in Asia and Europe, although the commercial value of these efforts has not yet been demonstrated.
Arrive AI Stock Down 7.0%
Shares of NASDAQ ARAI traded down $0.02 during mid-day trading on Thursday, reaching $0.24. 1,000,041 shares of the company were exchanged, compared to its average volume of 4,495,691. Arrive AI has a 52 week low of $0.22 and a 52 week high of $6.86. The stock has a market capitalization of $12.55 million, a PE ratio of -0.47 and a beta of 4.31. The company’s 50 day moving average price is $0.38 and its 200 day moving average price is $0.79.
Wall Street Analyst Weigh In
Read Our Latest Report on ARAI
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in ARAI. Geode Capital Management LLC boosted its holdings in shares of Arrive AI by 15.7% in the 4th quarter. Geode Capital Management LLC now owns 123,571 shares of the company’s stock worth $325,000 after purchasing an additional 16,804 shares in the last quarter. State Street Corp lifted its position in Arrive AI by 193.6% in the 4th quarter. State Street Corp now owns 46,100 shares of the company’s stock worth $121,000 after buying an additional 30,400 shares during the last quarter. Two Sigma Investments LP purchased a new stake in Arrive AI in the third quarter worth approximately $106,000. PharVision Advisers LLC bought a new position in Arrive AI during the third quarter valued at approximately $60,000. Finally, Tower Research Capital LLC TRC purchased a new position in shares of Arrive AI during the second quarter worth approximately $133,000.
Arrive AI Company Profile
We were incorporated on April 30, 2020, in the State of Delaware under the name of Dronedek Corporation. The Company changed its name to Arrive Technology Inc on July 27, 2023. The Company changed its name to Arrive AI Inc on September 30, 2024. We are a developmental technology company with a focus on designing and implementing a commercially viable smart mailbox and platform system for smart, secure, and seamless exchange of packages, goods, supplies, food, and medications between people, through the use of robots, and drones.
Read More
- Five stocks we like better than Arrive AI
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Arrive AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arrive AI and related companies with MarketBeat.com's FREE daily email newsletter.
